Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity

British Journal of Cancer

Volumn 83, Issue 8, 2000, Pages 998-1002

  Misra, V ^a   Grondin, A ^a   Klamut, H J ^a   Rauth, A M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Activity; DT diaphorase; Genotype; Polymorphism; RT PCR RFLP

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ALLELE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN FIBROBLAST; WESTERN BLOTTING;

EID: 0033781709     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1359     Document Type: Article

References (21)

1. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy
2. Association of the NAD(P)H:quinone oxidoreductase 609C to T polymorphism with a decreased lung cancer risk
3. 'Touchdown' PCR to circumvent spurious priming during gene amplification
4. DT-diaphorase: A historical review
5. Transcriptional regulation of the rat NAD(P)H:quinone oxidoreductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants
6. Role of a DT-diaphorase mutation in the response of anal canal carcinoma to radiation, 5-fluorouracil and mitomycin C
7. Human NAD(P)H:quinone oxidoreductase 2. Gene structure, activity, and tissue-specific expression
8. Ethnic variation in the prevalence of a common NAD(P)H:quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
9. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity
10. DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family
11. Transfection of COS-1 cells with DT-diaphorase cDNA: Role of a base change at position 609
12. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues
13. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity
14. Lack of NAD(P)H:quinone oxidoreductase activity (NQO1) is associated with increased risk of benzene hematotoxicity
15. Cytosolic NAD(P)H: (quinone-acceptor)Oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol
16. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1
17. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
18. Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase)
19. Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid
20. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators
21. The experimental development of bioreductive drugs and their role in cancer therapy